Acurx Pharmaceuticals, Inc.
ACXP
$1.43
$0.00-0.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.66M | 9.25M | 7.56M | 5.91M | 6.06M |
| Total Receivables | 95.30K | 56.30K | 48.40K | 40.20K | 40.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 233.10K | 228.80K | 85.00K | 158.20K | 53.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 10.98M | 9.54M | 7.69M | 6.11M | 6.16M |
|
|
|||||
| Total Current Assets | 10.98M | 9.54M | 7.69M | 6.11M | 6.16M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.98M | 9.54M | 7.69M | 6.11M | 6.16M |
|
|
|||||
| Total Accounts Payable | 3.80K | 3.40K | 6.80K | 4.40K | 4.40K |
| Total Accrued Expenses | 2.83M | 2.52M | 2.41M | 2.46M | 2.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.83M | 2.53M | 2.42M | 2.47M | 2.59M |
|
|
|||||
| Total Current Liabilities | 2.83M | 2.53M | 2.42M | 2.47M | 2.59M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.83M | 2.53M | 2.42M | 2.47M | 2.59M |
|
|
|||||
| Common Stock & APIC | 87.38M | 83.98M | 80.56M | 77.35M | 75.28M |
| Retained Earnings | -79.22M | -76.97M | -75.29M | -73.71M | -71.72M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 8.15M | 7.01M | 5.27M | 3.64M | 3.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.15M | 7.01M | 5.27M | 3.64M | 3.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.15M | 7.01M | 5.27M | 3.64M | 3.57M |
|
|
|||||